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the assembly and O-GlcNAc modification of the
mSin3A/HDAC1/2 complex in the heart
Emily J Cox1 and Susan A Marsh2*Abstract
Background: Exercise causes physiological cardiac hypertrophy and benefits the diabetic heart. Mammalian
switch-independent 3A (mSin3A) and histone deacetylases (HDACs) 1 and 2 regulate hypertrophic genes through
associations with the DNA binding proteins repressor element-1 silencing transcription factor (REST) and O-linked
β-N-acetylglucosamine transferase (OGT). O-linked β-N-acetylglucosamine (O-GlcNAc) is a glucose derivative that is
chronically elevated in diabetic hearts, and a previous study showed that exercise reduces cardiac O-GlcNAc. We
hypothesized that O-GlcNAc and OGT would physically associate with mSin3A/HDAC1/2 in the heart, and that this
interaction would be altered by diabetes and exercise.
Methods: 8-week-old type 2 diabetic db/db (db) and non-diabetic C57 mice were randomized to treadmill exercise
or sedentary groups for 1 or 4 weeks.
Results: O-GlcNAc was significantly higher in db hearts and increased with exercise. Db hearts showed lower levels
of mSin3A, HDAC1, and HDAC2 protein, but higher levels of HDAC2 mRNA and HDAC1/2 deacetylase activity.
Elevated HDAC activity was associated with significantly blunted expression of α-actin and brain natriuretic peptide
in db hearts. In sedentary db hearts, co-immunoprecipitation assays showed that mSin3A and OGT were less
associated with HDAC1 and HDAC2, respectively, compared to sedentary C57 controls; however, exercise removed
these differences.
Conclusions: These data indicate that diabetes and exercise oppositely affect interactions between pro-hypertrophic
transcription factors, and suggest that an increase in total cardiac O-GlcNAc is a mechanism by which exercise benefits
type 2 diabetic hearts.
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Cardiac hypertrophy is the adaptive enlargement of the
myocardium in response to physical or neurohormonal
stress. Type 2 diabetes is associated with a cardiac
syndrome called diabetic cardiomyopathy, which is char-
acterized by pathological hypertrophy, contractile dysfunc-
tion [1,2], and an intractable reliance on fatty acid
oxidation [3-5]. By contrast, chronic endurance exercise
training causes physiological hypertrophy that improves
contractile mechanics [6,7] and myocardial metabolism* Correspondence: susan.marsh@wsu.edu
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reproduction in any medium, provided the or[8,9]. Exercise benefits the type 2 diabetic heart [10-14],
but the underlying mechanisms by which exercise and
diabetes control cardiac hypertrophy are not well understood.
In non-diabetic hearts, activation of fetal genes is a pro-
tective mechanism [15-17] that accompanies pathological
hypertrophy [17-21]. These fetal genes include fetal cyto-
skeletal proteins (skeletal α-actin, β-myosin heavy chain)
and the atrial and brain natriuretic peptides (ANP and
BNP) [22-24]. Importantly, exercise and diabetes moderate
these genes differently. Exercise increases adult cardiac α-
actin [25], but does not change fetal gene expression [26],
whereas type 2 diabetes actually reduces circulating natri-
uretic peptides [27,28], and blocks the activation of fetal
genes by hypertrophic stimuli in vitro [29]. This suggestsral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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from that of exercised hearts and non-diabetic hearts, and
therefore, may underlie the hypertrophic response to these
conditions.
A potential mechanism for the effects of diabetes and
exercise on fetal genes is through the post-translational
modification of transcription factors by O-linked β-N-
acetylglucosamine (O-GlcNAc). O-GlcNAc is a glucose
derivative that post-translationally modifies serine/threo-
nine residues [30,31]. O-GlcNAcylation modifies signal
transduction in a manner analogous to phosphorylation;
O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA)
add and remove the O-GlcNAc moiety, respectively. We
have recently shown that O-GlcNAc modifies repressor
element-1 silencing transcription factor (REST) [32],
a transcription factor that represses fetal genes by recrui-
ting the corepressors mammalian switch-independent 3A
(mSin3A) and histone deacetylases (HDACs) 1 and 2
[33]. The HDAC enzymes deacetylate histone tails, thus
condensing euchromatin and silencing gene expression;
HDAC1 and HDAC2 specifically mediate fetal gene regu-
lation by REST and mSin3A, and have been repeatedly
linked to hypertrophic growth of the heart [34].
mSin3A and HDAC1 are O-GlcNAcylated in HepG2
liver carcinoma cells, and are recruited to gene loci by
the OGT enzyme [35], which also O-GlcNAcylates itself
[30]. The activity of OGT is regulated by cellular con-
centrations of UDP-GlcNAc substrate [36,37], which is
increased in the diabetic heart [38]. Indeed, total O-
GlcNAc and protein O-GlcNAcylation are elevated in
the diabetic heart [4,39], but the functional implications
of this finding are unclear as elevated cardiac O-GlcNAc
is implicated in heart failure and cardiac dysfunction
[39,40], but also cardioprotection [41,42]. Nevertheless,
two previous studies showed that total protein O-
GlcNAcylation and O-GlcNAcylation of the SP1 tran-
scription factor are lowered by swimming exercise in
both non-diabetic and streptozotocin-induced type 1
diabetic hearts [43,44], and OGA overexpression directly
ameliorates the cardiovascular complications of type 2
diabetes [38].
We therefore hypothesized that a reduction in O-
GlcNAc may be a mechanism by which exercise benefits
the type 2 diabetic mouse heart. However, since these
interactions have not been studied in the heart, the second-
ary purpose of this study was to characterize the effects of
diabetes and moderate exercise on the mSin3A/HDAC1/2
complex. We used 4 weeks of moderate treadmill exercise
training to investigate the early signaling mechanisms in
the hypertrophic process. We show that exercise increases
total protein O-GlcNAcylation in the type 2 diabetic
db+/db+ mouse heart, and that exercise and diabetes have
reciprocal effects on the association of HDAC1 and
HDAC2 with fetal gene-regulating transcription factors.Methods
Animal care and facilities
The procedures in this study followed the guidelines of
the Washington State University Institutional Animal
Care and Use Committee and the Guide for the Care
and Use of Laboratory Animals published by the Na-
tional Institutes of Health (NIH publication no. 85–23,
revised 1996). 8-week-old type 2 diabetic mice (B6.BKS
(D)-Leprdb/J, db+/db+ (db) and age-matched C57BL/6J
non-diabetic lean db+/? background strain controls
(C57) were purchased from Jackson Laboratories (Bar
Harbor, ME). To control for activity, mice were singly
housed without environmental enrichment in a climate-
controlled vivarium on a 12:12 light:dark cycle. Mice
consumed water and standard chow ad libitum, except
for one overnight fast per week prior to blood glucose
measurement.
Exercise training protocol
Mice ran on a 6-lane electric treadmill (Columbus In-
struments, Columbus, OH) for 5 consecutive days a
week with 2 days of rest. In week 0, all mice were accli-
mated to the treadmill by standing on the stationary belt
for 10 min, then walking at 5 m/min for 20 min. Mice
were then randomized to sedentary (n = 11) or exercise
(n = 12) groups for 1 week, or sedentary (n = 16) or exer-
cise (n = 15) groups for 4 weeks. Human patients with
type 2 diabetes are commonly prescribed an exercise in-
tensity of at least 40-60% of their aerobic capacity, but a
higher intensity is recommended for maximum health
benefits [45]. Therefore, we exercised mice at 10 m/min,
which corresponds to approximately 70% of maximal
oxygen uptake (VO2max) for the C57 strain [46]. Mice
ran at this speed at 0% grade for 10, 20, 30, or 40 min in
weeks 1, 2, 3, and 4, respectively. O-GlcNAc is a highly
dynamic stress response; therefore, to remove con-
founding effects of stress, we kept the treadmill covered,
and used gentle tactile stimuli rather than the electro-
shock apparatus to keep mice running. Sedentary groups
were handled identically and spent equal time in the
same treadmill environment on a stationary belt.
Blood glucose and body weight measurements
Blood glucose and body weight were measured weekly
after an overnight fast. Blood glucose was measured with
a glucometer (ACCU-CHEK® Aviva, Roche Diagnostics,
Indianopolis, IN) in a small sample of tail blood. Glucose
readings that exceeded the accuracy limit of the cali-
brated meter (33.3 mmol/L) were imputed this value for
statistical analysis.
Tissue harvesting and morphological measurements
Following an overnight fast, mice were anesthetized rap-
idly using an isoflurane vaporizer chamber with 2-4%
Table 1 Antibodies
Target Supplier Cat #
CTD 110.6 (anti-O-
GlcNAc)
Gift from Mary-Ann Accavitti, University
of Alabama at Birmingham
n/a
RL2 (anti-O-GlcNAc) Abcam, Cambridge, MA 2739
anti-mSin3A Abcam 3479
anti-OGT Abcam 50271
anti-NCOAT/OGA Santa Cruz Biotechnology, Santa Cruz, CA sc-
66612
anti-HDAC1 Cell Signaling, Beverly, MA 5356





Millipore, Billerica, MA 07-
1575
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decapitated and blood glucose was measured in neck
blood. Whole hearts were excised and the atria were re-
moved. Ventricular tissue was immediately wet-weighed,
cut into four equal tissue aliquots, snap-frozen in liquid
nitrogen, and stored at −80°C. The left tibia was dis-
sected from each animal and measured from the tibial
plateau to the lateral malleolus.
Western blotting
Ventricular tissue was homogenized in Tissue Protein
Extraction Reagent (Sigma-Aldrich, St. Louis, MO);
20 mM sodium fluoride; 1 mM sodium orthovanadate;
3% protease inhibitor cocktail (Sigma); and 0.02%
PUGNAc, an OGA inhibitor (Sigma), to inhibit O-GlcNAc
removal from proteins. Total protein was quantified with a
modified Lowry assay (BioRad, Hercules, CA). Proteins
were separated by SDS-PAGE and transferred onto PVDF
membranes, which were probed overnight at 4°C with pri-
mary antibodies (anti-HDAC1 and -HDAC2, Cell Signaling,
Beverly, MA; anti-mSin3A, -REST, -OGT, and -calsequestrin,
Abcam, Cambridge, MA; anti-NCOAT/OGA, Santa Cruz






α-skeletal actin TTGTGCACCGCAAATGCTTCTAGG G
α-cardiac actin TGTAGGTGATGAAGCCCAGAGCAA T
β-myosin heavy chain TGGCTGGTGAGGTCATTGACAGAA T
GAPDH TGTGATGGGTGTGAACCACGAGAA C(Ser 421/423), Millipore, Billerica, MA), then probed with
the appropriate secondary antibodies for 1 hour at room
temperature (see Table 1 for antibody details). Chemilu-
minescent substrates (Thermo Fisher Scientific, Rockford,
IL) were used to detect horseradish peroxidase activity on
a ChemiDoc (BioRad). Protein levels were quantified on
duplicate blots with standard densitometry using ImageJ
software (National Institutes of Health, Bethesda, MD),
and normalized to the loading control calsequestrin.O-GlcNAc Western blotting
Ventricular lysates were separated with SDS-PAGE and
transferred to nitrocellulose membranes. Membranes were
blocked overnight at 4°C, probed with 1:5000 anti-
O-GlcNAc antibody (CTD 110.6, generous gift of Mary-
Ann Accavitti, University of Alabama at Birmingham),
then probed with the appropriate secondary antibody.
Horseradish peroxidase activity was detected on x-ray film
with chemiluminescent substrate (Thermo Scientific) and
quantified as described above for Western blotting.Co-immunoprecipitation
Ventricular tissue was homogenized in Tissue Protein
Extraction Reagent, 1% phosphatase inhibitor, 2% prote-
ase inhibitor (Sigma), and 0.02% PUGNAc. Lysates were
assayed for total protein as described for Western blot-
ting. Samples were diluted to equal protein concentra-
tions and precleared over protein A/G agarose beads
(Thermo Fisher Scientific) at 4°C for 4 hours. Precleared
supernatants were then added to 25 ul of beads that had
been incubated with primary antibody for 4 hours at
4°C. IP was performed overnight at 4°C; beads were then
washed and eluted at 100°C for 5 min. The eluents were
assayed for co-immunoprecipitated proteins using im-
munoblotting. The positive control was ventricular
lysate; the negative control was ventricular lysate
that was immunoprecipitated without antibody. Co-
immunoprecipitated proteins were normalized to the
level of captured target protein for analysis.everse Amplicon Annealing








ATGAGCCCTTCCACAATGCCAAA 133 Per plate
Table 3 Morphological data
1 Week
Wet heart (mg) Tibia (mm) Heart:tibia (mg:mm) N
C57 Sed 115 ± 4 22.5 ± 0.2 5.13 ± 0.18 11
C57 Ex 111 ± 4 23.0 ± 0.2 4.83 ± 0.18 12
Db Sed 114 ± 3 22.4 ± 0.1 5.08 ± 0.14 11
Db Ex 116 ± 3 22.3 ± 0.2 5.20 ± 0.15 12
4 Week
Wet heart (mg) Tibia (mm) Heart:tibia (mg:mm) N
C57 Sed 113 ± 2 23.5 ± 0.1 4.82 ± 0.09 16
C57 Ex 105 ± 2 23.4 ± 0.1 4.50 ± 0.10 15
Db Sed 123 ± 4* 22.6 ± 0.1* 5.45 ± 0.15* 16
Db Ex 119 ± 3* 22.4 ± 0.1* 5.30 ± 0.13* 15
*p < 0.05, significant effect of genotype.
Results are presented as mean ± SEM.
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HDAC enzyme activity was assayed with a colorimetric kit
(Enzo Life Sciences, Farmingdale, NY) per the manufac-
turer’s instructions. The substrate for this assay is predom-
inantly deacetylated by HDAC1/2 and sirtuin 1 (a class III
HDAC), but not the class II HDACs. Optical density was
read at 415 nm. Results are presented as fold changes
from control absorbance.
RNA isolation and quantitative real-time PCR (qPCR)
RNA was isolated with an RNA isolation kit (Qiagen,
Valencia, CA) and quantified on a NanoPhotometer™ spec-
trophotometer (Implen, Ontario, NY). Complementary
DNA (cDNA) was generated using a cDNA synthesis kit
(Thermo Fisher Scientific). qPCR was performed in tripli-
cate with SYBR green fluorescence chemistry using a qPCR
kit (Qiagen). The negative control contained water in place
of cDNA template. Thermal cycling was performed on an
iCycler iQTM Real Time PCR Detection System (Biorad)
using the following cycle: 95°C for 10 min, and 40 cycles of
95°C for 30 sec and Tm for 10 sec. Primer specificity was
confirmed by melting curve analysis. Amplification data
were analyzed with the 2-ΔΔCt method for normalization to
the housekeeping gene GAPDH as previously described
[47]. See Table 2 for primer details.
Statistics
Longitudinal effects of genotype and exercise on body
weight and blood glucose were analyzed with two-factor
repeated measures ANOVA followed by Bonferroni post-
hoc tests. Non-normal data were log transformed prior to
analysis. Two-factor ANOVA with Bonferroni post-hoc
tests were used to describe genotype and exercise effects
on protein levels, HDAC activity, and gene expression.
Cardiac hypertrophy, tibia length, and wet heart weight
data were resistant to transformations of normality and
were analyzed with Kruskal-Wallis analysis of variance
followed by Dunn’s post-hoc test. Values are presented as
mean ± SEM and significance was accepted at P < 0.05.A
Figure 1 Effect of 4 weeks of treadmill exercise training on fasting bl
mice. Ex = exercise (n = 15 per group); Sed = sedentary (n = 16 per group). * S
effect of time from previous consecutive time point, P < 0.05.Results
Db mice show obesity, hyperglycemia, and cardiac
hypertrophy despite 4 weeks of exercise
Fasting blood glucose and body weight in db mice were
significantly elevated relative to controls, and increased
over the duration of the protocol (Figure 1) as the db mice
developed overt diabetes. Exercise did not alter either va-
riable in db mice; this is consistent with previously de-
scribed work by others [27,48,49]. There were no
differences in cardiac hypertrophy at 1 week; however, db
mice showed overt cardiac hypertrophy (heart weight:tibia
length) at the 4 week time point (Table 3). Tibia length
was also significantly reduced in db mice at the 4 week
time point, consistent with previous reports of reduced
linear skeletal growth in db mice [50,51].
Total protein O-GlcNAcylation is increased by exercise in
db mouse hearts
Exercise training increased cardiac O-GlcNAc in db mouse
hearts at the 1 week time point; however, at this time point,
protein levels of OGT and OGA were not different betweenB
ood glucose and body weight in C57BL/6J (C57) and db/db (db)
ignificant effect of genotype within a time point, p < 0.05. ǂ Significant



















































































































































Figure 2 1 week of exercise increases total protein O-GlcNAcylation in db/db mouse hearts. (A) Western blot and (B-G) quantification of
total protein O-GlcNAcylation in ventricular tissue from C57BL/6J (C57) and db/db (db) mice that were exercised (Ex) or sedentary (Sed) for
1 week. O-GlcNAc levels are normalized to the loading control calsequestrin (Csq). N = 6 per group. * Significant effect of genotype within an
exercise group, P < 0.05. # Significant effect of exercise within a genotype group, P < 0.05. ‡ Significant interaction of exercise x genotype, P < 0.05.






























































































































































Figure 3 4 weeks of exercise increases total protein O-GlcNAcylation in db/db mouse hearts. (A) Western blot and (B-G) quantification of
total protein O-GlcNAcylation in ventricular tissue from C57BL/6J (C57) and db/db (db) mice that were exercised (Ex) or sedentary (Sed) for 1 week.
O-GlcNAc levels are normalized to the loading control calsequestrin (Csq). N = 6 per group. * Significant main effect of genotype, P < 0.05.
# Significant effect of exercise within a genotype group, P < 0.05. ‡ Significant interaction of exercise x genotype, P < 0.05.
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http://www.cardiab.com/content/12/1/101groups (Figure 2). At 4 weeks, O-GlcNAc was elevated in
db hearts relative to controls, and was significantly in-
creased by exercise (Figure 3). As densitometry of the entire
sample lane is dominated by the intense immunoreactive
bands at 37 and 82 kDa, the analysis was also performed
over the high, mid and low molecular weight ranges, which
showed the same exercise-induced increases in db hearts.
At this timepoint, levels of OGA and OGT were also sig-
nificantly increased in db hearts relative to controls, inde-
pendent of exercise.
To analyze these effects further, we then analyzed O-
GlcNAc by weight range within each genotype. Analysis
of O-GlcNAc by weight range revealed a modest but sig-
nificant decrease in total protein O-GlcNAcylation with
exercise. Interestingly, however, we also observed an in-
crease in O-GlcNAc on total and high molecular weight
proteins over time in C57 hearts (Figure 4C). In db mice,Csq
– – – +    +    +      – – – +     +     +      Ex

















































































































Figure 4 Effects of 1 and 4 weeks of treadmill exercise on total prote
C57BL/6J hearts. (A) Western blot and (B-E) quantification of total protein
treadmill exercised (Ex) or sedentary (Sed) for 1 or 4 weeks. (F) Western blot an
tissue from Ex or Sed (db) mice. O-GlcNAc levels are normalized to the loading
within an exercise group, P<0.05. # Significant effect of exercise within a time phowever, total and high molecular weight O-GlcNAc
increased over time (Figure 4G), and O-GlcNAcylation
of mid and low molecular weight were increased by ex-
ercise (Figure 4I-J).
Diabetes reduces mSin3A/HDAC1/HDAC2 protein levels in
the heart
REST protein levels were not different between groups
at either time point (Figures 5 and 6). At the 1 week
time point, mSin3A and HDAC1 were significantly lower
in db hearts, independent of exercise (Figure 5). At the
4 week time point, mSin3A, HDAC1, as well as HDAC2
protein levels were significantly lower in db hearts, again
independent of exercise (Figure 6). Exercise training
reduced mSin3A levels in non-diabetic control hearts;
however, mSin3A levels were even lower in db hearts
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in O-GlcNAcylation in type 2 diabetic db/db and non-diabetic
O-GlcNAcylation in ventricular tissue from C57 mice that were
d (G-J) quantification of protein O-GlcNAcylation levels in ventricular
control calsequestrin (Csq). N=6 per group. * Significant effect of time
oint, P<0.05. ‡ Significant interaction of exercise group x time, P<0.05.
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OGT:HDAC2 association in db mouse hearts
As stated above, cardiac hypertrophy as measured by
heart weight:tibia length was not apparent at 1 week but
was evident in db hearts at 4 weeks (Table 3); therefore,
we analyzed the association of hypertrophy-regulating
transcription factors in the 4 week group only. Co-
immunoprecipitation of OGT showed that diabetes re-
duced the OGT:HDAC2 association (P < 0.05), but this
difference was removed by exercise training (Figure 7).
OGT association with mSin3A and HDAC1 was not dif-
ferent between groups. OGT was also modestly more as-
sociated with REST in sedentary db hearts compared to
sedentary controls (P < 0.05).
Reciprocal co-immunoprecipitation of mSin3A showed
that there were no differences in its association with OGT
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C57A
*
Figure 5 Effects of diabetes and 1 week of exercise on protein levels
diabetic db/db and non-diabetic C57BL/6J hearts. (A) Western blot and
complex in C57BL/6J (C57) and db/db (db) mice who were treadmill exerci
* Significant main effect of genotype, P < 0.05.more associated with REST in db hearts. Finally, the asso-
ciation of mSin3A with HDAC1 was significantly lower in
sedentary db hearts compared to sedentary controls, and
this difference was removed by exercise.
It was recently reported that exercise reduces the O-
GlcNAcylation of Specificity Protein 1 transcription factor
(SP1) [43,44]. Therefore, we investigated whether exercise
would alter the O-GlcNAc modification of mSin3A, a tran-
scription factor that is directly involved in hypertrophic sig-
naling. Although mSin3A immunoprecipitation appeared
to show that the O-GlcNAcylation of mSin3A was in-
creased by exercise (Figure 8A-B), reciprocal immunopre-
cipitation of O-GlcNAc did not confirm this effect (data
not shown). Therefore, this effect of exercise should be
viewed with caution.
Finally, we performed co-immunoprecipitation of HDAC1




































of the mSin3A/HDAC1/2 transcription factor complex in type 2
(B-E) quantification of members of the mSin3A/REST/HDAC1/2


































































Figure 6 Effects of diabetes and 4 weeks of exercise on protein levels of the mSin3A/HDAC1/2 transcription factor complex in type 2
diabetic db/db and non-diabetic C57BL/6J hearts. (A) Western blot and (B-E) quantification of members of the mSin3A/REST/HDAC1/2
complex in C57BL/6J (C57) and db/db (db) mice who were treadmill exercise trained (Ex) or sedentary (Sed) for 4 weeks. N=6 per group. * Significant
main effect of genotype, P<0.05; # Significant effect of exercise within a genotype group, P<0.05.
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effect of exercise on the HDAC1:mSin3A interaction; the as-
sociation of mSin3A with HDAC1 was lower in sedentary db
hearts relative to sedentary C57 controls, but exercise re-
moved this difference.
HDAC activity is increased in db mouse hearts
Phosphorylation of HDAC1 at serine 421 and 423 is
specifically associated with HDAC1 activation [52];
therefore, we immunoprecipitated HDAC1 and immu-
noblotted for phospho-HDAC1 (Ser421/423). This
showed that HDAC1 phosphorylation was significantly
elevated in db hearts independent of exercise (P < 0.05)
(Figure 9D). Colorimetric assay confirmed that class I
HDAC activity was significantly higher in db mice inde-
pendent of exercise (Figure 9E).Diabetes blunts fetal gene expression in the heart
We investigated whether changes in these transcription
factor interactions were associated with changes in the
expression of fetal genes, such as ANP, BNP, and skeletal
α-actin, which are regulated by REST and mSin3A [20,53].
Transcript levels of ANP and β-myosin heavy chain were
not different between groups, but BNP and skeletal α-
actin were signifi- cantly reduced in db hearts independ-
ent of exercise (Figure 10). HDAC2 gene expression was
elevated in db hearts independent of exercise, and cardiac
α-actin showed a prominent trend to be induced by exer-
cise (P = 0.050) (Figure 10).
Discussion
While diabetes is a multifactorial cardiac insult, and dia-
betic cardiomyopathy is associated with multiple factors








































































Figure 7 Effects of diabetes and 4 weeks of exercise on the association of mSin3A/HDAC1/2 complex with OGT in type 2 diabetic db/db
and non-diabetic C57BL/6J hearts. (A) Immunoblot and (B-E) blot quantification showing the association of OGT with the mSin3A/REST/
HDAC1/2 complex in C57BL/6J (C57) and db/db (db) mice who were treadmill exercise trained (Ex) or sedentary (Sed) for 4 weeks. N = 3 per
group. * Significant effect of genotype within exercise group, P < 0.05.
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http://www.cardiab.com/content/12/1/101such as oxidative stress [54], lipotoxicity and mitochondrial
dysfunction [55-57], and impaired calcium signaling [13],
O-GlcNAc is emerging as an important signalling mech-
anism in the development of diabetic cardiomyopathy.
Total protein O-GlcNAcylation is chronically elevated
in the type 1 and 2 diabetic heart [4,39], and reducing pro-
tein O-GlcNAcylation by adenoviral overexpression of
OGA [38] improves cardiac function. Similarly, lowering
O-GlcNAc by intensive swim training [43,44] has been
proposed as a mechanism by which exercise benefits the
diabetic heart, and exercise lowers both the O-GlcNAc
modification of the SP1 transcription factor and the OGT
enzyme. O-GlcNAc directly mediates the expression of
fetal genes in response to hypertrophic stimuli [29], and
O-GlcNAc modifies mSin3A and HDAC1 [35], which
regulate cardiac hypertrophy [20,58]. Previously, wehave shown that exercise lowers the O-GlcNAc modi-
fication of the OGT enzyme [32], and others have
shown that exercise lowers O-GlcNAcylation of the
SP1 transcription factor [43]. Moderate exercise
improves cardiac structure and function in humans
with type 2 diabetes [59,60]; we therefore tested the
hypothesis that moderate exercise would reduce O-
GlcNAc in the type 2 diabetic heart, and would be as-
sociated with changes in the O-GlcNAc modification
and activity of the mSin3A/HDAC1/2 transcription
factor complex, which regulates hypertrophic genes.
Surprisingly, and in contrast with the previous studies,
we found that 4 weeks of moderate treadmill exercise
increased total O-GlcNAc in type 2 diabetic db mouse
hearts. Also, while the previous studies showed that OGT
was also reduced by exercise [43,44], we found that OGT


































































































Figure 8 Effects of diabetes and 4 weeks of exercise on the interaction of mSin3A/HDAC1/2 with OGT and O-GlcNAc in type 2 diabetic
db/db and non-diabetic C57BL/6J hearts. (A) Immunoblot and (B-F) blot quantification showing the O-GlcNAc modification and the
association of the mSin3A/REST/HDAC1/2 complex with OGT in C57BL/6J (C57) and db/db (db) mice who were treadmill exercise trained (Ex) or
sedentary (Sed) for 4 weeks. N = 6 per group. * Significant effect of genotype within exercise group, P < 0.05. # Significant effect of exercise within
a genotype group, P < 0.05. ‡ Significant main effect of exercise, P < 0.05.
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not change with exercise. Such parallel regulation of OGT
and OGA expression has been previously reported [41],
and may represent a compensatory relationship between
these two opposing enzymes. The difference in our
findings may be due to the use of type 2 db mice rather
than streptozotocin-induced type 1 diabetic mice, andthe use of moderate treadmill exercise rather than more
intensive swimming exercise. However, other studies
have shown that an upregulation of O-GlcNAc is essen-
tial in the cardiac stress response [61,62], is acutely
cardioprotective [63,64], and is part of a constitutively
active cardioprotection mechanism in the diabetic myo-
cardium [42]. Therefore, these data suggest that an



































































Figure 9 Effects of diabetes and 4 weeks of exercise on HDAC1 activation and the mSin3A/HDAC1 interaction. (A) Immunoprecipitation
(IP) of HDAC1 and immunoblot for its association with mSin3A in ventricular tissue from C57BL/6J (C57) and db/db (db) mice that were treadmill
exercised (Ex) or sedentary (Sed) for 4 weeks. (B) Immunoprecipitation (IP) of HDAC1 and immunoblot for phospho-serine 421/423, which
activates HDAC1. (C-D) Blot quantification of (A) and (B). (E) Colorimetric assay quantification of class 1 HDAC activity in ventricular tissue. N = 6
per group for HDAC1 immunoprecipitation; N = 3 per group for HDAC1/2 activity assay. * Significant effect of genotype within an exercise group,
P < 0.05. # Significant main effect of genotype, P < 0.05.
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http://www.cardiab.com/content/12/1/101increase in cardiac O-GlcNAc in the type 2 diabetic
heart may be a beneficial effect of exercise.
In our study, mSin3A immunoprecipitation revealed
that exercise increased the O-GlcNAc modification of
mSin3A; however, this was not supported by reciprocal
O-GlcNAc immunoprecipitation. It is possible that
the large amount of protein captured in the O-GlcNAc
immunoprecipitation masked the changes in mSin3A































Figure 10 mRNA transcript levels in ventricular tissue from C57BL/6J
sedentary (Sed) for 4 weeks. mRNA levels are normalized to the loading
α-actin; N = 6 all other groups. * Significant main effect of genotype, P < 0.0specific mSin3A immunoprecipitation. However, these
data underscore the importance of verifying changes in
O-GlcNAcylation of individual proteins with reciprocal
assays, and suggest that moderate changes in protein O-
GlcNAcylation – including those in the present study –
should be interpreted cautiously and confirmed by
additional studies.
Nevertheless, our data do suggest an alternate mechan-





(C57) or db/db (db) mice that were treadmill exercised (Ex) or
control GAPDH using the 2-ΔΔCt method. N = 8 per group for cardiac
5. # Near-significant main effect of exercise, Ptrend = 0.050.
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HDAC1, and HDAC2, and an increased association of
mSin3A with REST, independent of exercise. Likewise,
mRNA transcript levels of BNP and α-skeletal actin, which
are typical markers of cardiac hypertrophy activated by
HDAC1/2 [65] that are regulated via REST/mSin3A [33],
were significantly lower in db hearts independent of exer-
cise. The finding that blunted expression of fetal genes in
diabetic hearts is not altered by exercise has been shown
in previous studies [27,28]. Therefore, we suggest that
the loss of HDAC1/2 and the increased association
of the mSin3A corepressor with REST may underlie
the blunted expression of fetal genes in the diabetic
heart. Further, since the natriuretic peptides are both
anti-hypertrophic and cardioprotective [15,17,28], we
suggest that this mechanism may be responsible for the
increased vulnerability of the diabetic heart to stress and
heart failure [66,67].
Although we did not measure the structural or hemo-
dynamic effects of the exercise protocol in db hearts, previ-
ous work has shown that the db heart shows similar
cardiomyopathy to humans with type 2 diabetes [68,69],
which are improved by exercise [13,14]. We show addition-
ally that even the low intensity of exercise used in this
protocol was sufficient to elevate the expression of cardiac
α-actin in C57 hearts (P = 0.050). Cardiac α-actin is a
marker of cardiomyocyte differentiation and hypertrophy
[70], and is increased in physiologically hypertrophied
hearts after chronic endurance exercise training [25]. Add-
itional transcriptional changes were observed in db hearts,
in which the exercise protocol significantly increased
the association of mSin3A and OGT with HDAC1 and
HDAC2, respectively. Therefore, although the exercise
stimulus used in this study did not cause overt changes in
cardiac mass, it induced transcriptional events consistent
with the early stages of physiological cardiac remodelling.
Finally, these data show a potential interaction be-
tween HDAC1 and HDAC2 that has not previously been
described in the heart. HDAC1 and HDAC2 regulate
cardiac hypertrophy in a similar manner [58], and
HDAC1 deficiency induces HDAC2 expression in em-
bryonic stem cells [71]. In our study, the loss of HDAC1
protein preceded the loss of HDAC2 protein in db
hearts, and was similarly associated with an increase in
HDAC2 gene expression in db hearts. When HDAC2
deficiency was present at the 4 week time point, we ob-
served an increase in the total activity of class I HDACs
in db hearts, which was verified by an increase in the
phosphorylation status of HDAC1 at Ser421/423. Phos-
phorylation at these residues is specifically associated
with HDAC1 activity [52]. Therefore, these data suggest
that the class I HDACs have compensatory effects on
each other’s expression levels and activation by phos-
phorylation. Further, the reduction in HDAC2 proteinlevels in db mouse hearts did not occur until 4 weeks,
and was associated with overt cardiac hypertrophy.
Thus, the loss of HDAC2 in the diabetic heart is associ-
ated with the progression of hypertrophy in the diabetic
heart, and may be more specifically involved in hyper-
trophy than HDAC1.
Conclusions
These data show that exercise increases O-GlcNAc in the
type 2 diabetic db mouse heart, and that components of
the mSin3A/HDAC1/2 chromatin-modifying complex
interact with O-GlcNAc and OGT. Contrary to our hy-
pothesis, exercise increased cardiac O-GlcNAc in the dia-
betic heart; this signalling mechanism may underlie the
beneficial effect of exercise in the pathologically hypertro-
phied diabetic heart. Finally, we found that diabetes and
exercise reciprocally affected the physical associations of
mSin3A/HDAC1/2. The effects of exercise observed in
this study were generally modest, which suggests that a
moderate level of exercise, such as that prescribed for hu-
man patients with diabetes, does not have extreme effects
on the mSin3A/HDAC1/2 complex. However, since this
complex is a key regulator of cardiac hypertrophy, the re-
sults of this study suggest that exercise-induced changes
in the association or activity of this complex may underlie
the beneficial effect of moderate exercise in the diabetic
heart.
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